Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-16
2009-08-04
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S211050, C514S220000, C514S221000, C540S488000, C540S490000, C540S495000, C540S496000, C540S506000
Reexamination Certificate
active
07569561
ABSTRACT:
The present invention encompasses compounds of general formula (1)whereinR1to R6, X and Y are defined as in claim1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, as well as the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.
REFERENCES:
patent: 2004/074244 (2004-09-01), None
patent: 2004/080980 (2004-09-01), None
patent: 2006/021544 (2006-03-01), None
ISR—PCT/EP2007/051599, (2007).
G. Wolf, et al., “Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer”, Oncogene, 1997, vol. 14, p. 543.
J. P. H. Th'ng, et al., “The FT210 Cell Line is a Mouse G2 Phase Mutant with a Temperature-Sensitive CDC2 Gene Product”, Cell, vol. 63, p. 313, 1990.
T. Takahashi, et al., “Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers”, Cancer Sci, 2003, vol. 94, No. 2, p. 148.
P. B. Schiff, et al., “Taxol stabilizes microtubules in mouse fibroblast cells”, Proc. Natl. Acad. Sci. USA, vol. 77, No. 3, pp. 1561, 1980.
P. Russell, et al., “Negative Regulation of Mitosis by wee1, a Gene Encoding a Protein Kinase Homolog”, Cell, vol. 49, p. 559, 1987.
P. Russell, et al., “cdc25 Functions as an Inducer in the Mitotic Control of Fission Yeast”, Cell, vol. 45, p. 145, 1986.
Y-W Qian, et al., “The Polo-like Kinase P1x1 Is Required for Activation of the Phosphatase Cdc25C and Cyclin B-Cdc2 in Xenopus Oocytes”, Molecular Biol of the Cell, vol. 12, p. 1791, 2001.
P. Nurse, “Universal control mechanism regulating onset of M-phase”, Nature, vol. 344, 1990, pp. 503.
T.U. Mayer, et al., “Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen”, Science, vol. 286, p. 971, 1999.
X. Liu, et al., “Polo-like kinase (PLK)1 depletion induces apoptosis in cancer cells”, PNAS, vol. 100, No. 10, p. 5789, 2003.
H.A. Lane, et al., “Antibody Microinjection Reveals an Essential Role for Human Polo-like Kinase 1 (PLK1) in the Functional Maturation of Mitotic Centrosomes”. J. Cell Biology, vol. 135. No. 6. part2, p. 1701, 1996.
R. Knecht, et al., “Prognostic Significance of Polo-like Kinase (PLK) Expression in Squamous Cell Carcinomas of the Head and Neck”, Cancer Research, vol. 59, p. 2794, 1999.
J-Y Hsu, et al., “Mitotic Phosphorylation of Histone H3 is Governed by IpI1/aurora Kinase and GIc7/pp1 Phosphatase in Budding Yeast and Nematodes”, Cell, vol. 102, p. 279, 2000.
D.M. Glover, et al., “Polo-like Kinases: a team that plays throughout mitosis”, Genes & Development, vol. 12, p. 3777, 1998.
G. Wolf, et al., “Polo-like Kinase: a Novel Marker of Proliferation: Correlation with Estrogen-receptor Expression in Human Breast Cancer”, Pathology Res. Pract. vol. 196, p. 753, 2000.
K. Nishio, et al., “Antitumor Effects of Butyrolactone I, a Selective cdc2 Kinase Inhibitor, on Human Lunch Cancer Cell Lines”, Anticancer Research, vol. 16, p. 3387, 1996.
E. Nigg, “Mitotic Kinases as Regulators of Cell Division and Its Checkpoints”, Nature Reviews / Molecular Cell Biology, vol. 2, p. 21, 2001.
ISA 237 Written Opinion—PCT/EP2007/051599 Translation, (2007).
Baum Anke
Boehmelt Guido
Engelhardt Harald
Quant Jens Juergen
Solca Flavio
Boehringer Ingelheim International GmbH
Bottino Anthony P.
Devlin Mary-Ellen M.
Kifle Bruck
Morris Michael P.
LandOfFree
2,4-diaminopyrimidines useful for treating cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4-diaminopyrimidines useful for treating cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-diaminopyrimidines useful for treating cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4132069